An integrated multi-study analysis of serum HAI antibody responses to Ann Arbor strain live attenuated influenza vaccine in children and adults

Trials in Vaccinology

Volumn 3, Issue , 2014, Pages 150-153

  Coelingh, Kathleen L ^a   Wu, Xionghua W ^a   Mallory, Raburn M ^a   Ambrose, Christopher S ^a  

^a MEDIMMUNE   (United States)

Author keywords

LAIV; Live attenuated influenza vaccine; Serum hai response

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHILD; DOSE RESPONSE; DRUG FORMULATION; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN TISSUE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MUCOSAL IMMUNITY; PRESCHOOL CHILD; SCHOOL CHILD; VACCINATION; VIRUS STRAIN;

EID: 84910078961     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2014.08.001     Document Type: Article

References (17)

1. Guidance for Industry Clinical Data Needed to Support the Licensure of Seasonal Inactivated Vaccines, U.S. Department of Health and Human Services Food and Drug Administration, Available at: 〈http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm091990.pdf〉, Accessed March 6, 2014.
2. S. Black, U. Nicolay, T. Vesikari, M. Knuf, G. Del Giudice, G. Della Cioppa, T. Tsai, R. Clemens, R. Rappuoli, Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children, Pediatr. Infect. Dis. J. 30 (2011) 1081-1085.
3. D. Hobson, R.L. Curry, A.S. Beare, A. Ward-Gardner, The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses, J. Hyg. (Lond.) 70 (1972) 767-777.
4. J.C. de Jong, A.M. Palache, W.E. Beyer, G.F. Rimmelzwaan, A.C. Boon, A.D. Osterhaus, Haemagglutination-inhibiting antibody to influenza virus, Dev. Biol. 115 (2003) 63-73.
5. A. Bandell, J. Woo, K. Coelingh, Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference, Expert Rev. Vaccines 10 (2011) 1131-1141.
6. T. Rowe, R.A. Abernathy, J. Hu-Primmer, W.W. Thompson, X. Lu, W. Lim, K. Fukuda, N.J. Cox, J.M. Katz, Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays, J. Clin. Microbiol. 37 (1999) 937-943.
7. A.C. Voordouw, W.E. Beyer, D.J. Smith, M.C. Sturkenboom, B.H. Stricker, Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002, Vaccine 28 (2009) 392-397.
8. Committee for Proprietary Medicinal Products, Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96), European Medicines Agency, Available at: 〈http://www.emea.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003945.pdf〉, Accessed January 13, 2014.
9. C.S. Ambrose, M.J. Levin, R.B. Belshe, The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults, Influenza Other Respi. Viruses 5 (2011) 67-75.
10. J.J. Treanor, K. Kotloff, R.F. Betts, R. Belshe, F. Newman, D. Iacuzio, J. Wittes, M. Bryant, Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses, Vaccine 18 (1999) 899-906.
11. T.G. Boyce, W.C. Gruber, S.D. Coleman-Dockery, E.C. Sannella, G.W. Reed, M. Wolff, P.F. Wright, Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children, Vaccine 18 (1999) 82-88.
12. C.S. Ambrose, X. Wu, T. Jones, R.M. Mallory, The role of nasal IgA in children vaccinated with live attenuated influenza vaccine, Vaccine 30 (2012) 6794-6801.
13. B.D. Forrest, M.W. Pride, A.J. Dunning, M.R. Capeding, T. Chotpitayasunondh, J.S. Tam, R. Rappaport, J.H. Eldridge, W.C. Gruber, Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children, Clin. Vaccine Immunol. 15 (2008) 1042-1053.
14. D.F. Hoft, E. Babusis, S. Worku, C.T. Spencer, K. Lottenbach, S.M. Truscott, G. Abate, I.G. Sakala, K.M. Edwards, C.B. Creech, M.A. Gerber, D.I. Bernstein, F. Newman, I. Graham, E.L. Anderson, R.B. Belshe, Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children, J. Infect. Dis. 204 (2011) 845-853.
15. X.S. He, T.H. Holmes, C. Zhang, K. Mahmood, G.W. Kemble, D.B. Lewis, C.L. Dekker, H.B. Greenberg, A.M. Arvin, Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines, J. Virol. 80 (2006) 11756-11766.
16. W. Zhu, B.W. Higgs, C. Morehouse, K. Streicher, C.S. Ambrose, J. Woo, G.W. Kemble, B. Jallal, Y. Yao, A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children, Vaccine 28 (2010) 2865-2876.
17. J.H. Kreijtz, R.A. Fouchier, G.F. Rimmelzwaan, Immune responses to influenza virus infection, Virus Res. 162 (2011) 19-30.